Company / Operating Income
Yubo International Biotech Ltd Operating Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$1.2M
FY2025
5-year range
-$1.8M / -$711.8K
FY2021-FY2025
Trend
+32.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$2M in FY2024 to -$48,000 in FY2019.
Based on SEC 10-K filings.
-$1M in FY2025.
Remained stable around -$1M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 32.9% year-over-year.
- Peak operating income was recorded in FY2019.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.2M | +32.9% |
| FY2024 | -$1.8M | -48.1% |
| FY2023 | -$1.2M | +0.9% |
| FY2022 | -$1.2M | -69.3% |
| FY2020 | -$711.8K | -1382.9% |
| FY2019 | -$48.0K | +17.2% |
| FY2018 | -$58.0K | +0.0% |
| FY2017 | -$58.0K | +61.1% |
| FY2016 | -$149.0K | -136.5% |
| FY2015 | -$63.0K | -34.0% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026